These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 9178834)

  • 21. The Scripps Clinic experience with cladribine (2-CdA) in the treatment of chronic lymphocytic leukemia.
    Saven A
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):28-33. PubMed ID: 8714614
    [No Abstract]   [Full Text] [Related]  

  • 22. 2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
    Delannoy A; Hanique G; Ferrant A
    N Engl J Med; 1993 Mar; 328(11):812; author reply 813. PubMed ID: 8094888
    [No Abstract]   [Full Text] [Related]  

  • 23. Pentostatin in chronic lymphocytic leukemia.
    Sauter C; Lamanna N; Weiss MA
    Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1217-22. PubMed ID: 18721115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias.
    Cheson BD; Vena DA; Barrett J; Freidlin B
    J Clin Oncol; 1999 Aug; 17(8):2454-60. PubMed ID: 10561309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-Chlorodeoxyadenosine for patients with B-cell chronic lymphocytic leukemia resistant to fludarabine.
    Saven A; Lemon RH; Piro LD
    N Engl J Med; 1993 Mar; 328(11):812-3. PubMed ID: 8094889
    [No Abstract]   [Full Text] [Related]  

  • 26. Cladribine in the treatment of chronic lymphocytic leukemia.
    Robak T
    Leuk Lymphoma; 2001 Feb; 40(5-6):551-64. PubMed ID: 11426528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-Chlorodeoxyadenosine therapy in chronic lymphocytic leukemia.
    Saven A; Piro L
    N Engl J Med; 1994 Jun; 330(25):1829-30. PubMed ID: 7910665
    [No Abstract]   [Full Text] [Related]  

  • 28. 2-Chlorodeoxyadenosine therapy in chronic lymphocytic leukemia.
    Juliusson G; Liliemark J
    N Engl J Med; 1994 Jun; 330(25):1828-9; author reply 1829-30. PubMed ID: 7910664
    [No Abstract]   [Full Text] [Related]  

  • 29. Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia.
    Robak T; Błasinka-Morawiec M; Krykowski E; Kasznicki M; Płuzanska A; Potemski P; Hellmann A; Zaucha JM; Lewandowski K; Dmoszynska A; Hansz J; Komarnicki M; Konopka L; Durzynski T; Ceglarek B; Sikorska A; Kotlarek-Haus S; Mazur G; Urasinski I; Zdziarska B; Maj S; Kopec I; Skotnicki AB; Dwilewicz-Trojaczek J; Grieb P
    Leuk Lymphoma; 1996 Aug; 22(5-6):509-14. PubMed ID: 8882965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.
    Lam CC; Ma ES; Kwong YL
    Am J Hematol; 2005 Aug; 79(4):288-90. PubMed ID: 16044456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
    Rai KR; Peterson BL; Appelbaum FR; Kolitz J; Elias L; Shepherd L; Hines J; Threatte GA; Larson RA; Cheson BD; Schiffer CA
    N Engl J Med; 2000 Dec; 343(24):1750-7. PubMed ID: 11114313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment options for newly diagnosed patients with chronic lymphocytic leukemia.
    Erba HP
    Curr Hematol Rep; 2004 Jan; 3(1):47-53. PubMed ID: 14695850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
    Liso V; Molica S; Capalbo S; Pogliani E; Battista C; Broccia G; Montillo M; Cuneo A; Leoni P; Specchia G; Castoldi G
    Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias.
    Pott-Hoeck C; Hiddemann W
    Ann Oncol; 1995 May; 6(5):421-33. PubMed ID: 7669706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New prospects in the treatment of indolent lymphomas with purine analogues.
    Cheson BD
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S27-36. PubMed ID: 9672772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purine analogs in chronic lymphocytic leukemia and Waldenström's macroglobulinemia.
    O'Brien S; Kantarjian H; Keating MJ
    Ann Oncol; 1996; 7 Suppl 6():S27-33. PubMed ID: 9010576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-Chlorodeoxyadenosine (2-CdA) in the treatment of patients with relapsed chronic lymphocytic leukemia.
    Krykowski E; Warzocha K; Robak T
    Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):317-21. PubMed ID: 8744653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purine analogue-based chemotherapy regimens for patients with previously untreated B-chronic lymphocytic leukemia.
    Kay NE
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S50-4. PubMed ID: 16549115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?
    Ahmadi T; Schuster SJ
    J Clin Oncol; 2009 Feb; 27(4):479-80. PubMed ID: 19075263
    [No Abstract]   [Full Text] [Related]  

  • 40. Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells.
    Bouzar AB; Boxus M; Defoiche J; Berchem G; Macallan D; Pettengell R; Willis F; Burny A; Lagneaux L; Bron D; Chatelain B; Chatelain C; Willems L
    Br J Haematol; 2009 Jan; 144(1):41-52. PubMed ID: 19006566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.